Zsuzsanna Papai Selected Research

Zsuzsanna Papai Research Topics

6	Neoplasms (Cancer) 06/2022 - 01/2012
3	Fatigue 11/2021 - 05/2014
3	Sarcoma (Soft Tissue Sarcoma) 01/2021 - 12/2015
3	Stomatitis 01/2020 - 05/2014
3	Neutropenia 01/2017 - 05/2014
3	Febrile Neutropenia 01/2017 - 05/2014
2	Gastrointestinal Stromal Tumors (Gastrointestinal Stromal Tumor) 06/2022 - 01/2019
2	Colorectal Neoplasms (Colorectal Cancer) 03/2020 - 01/2012
2	Disease Progression 01/2017 - 05/2014
2	Breast Neoplasms (Breast Cancer) 05/2014 - 09/2010
1	Ovarian Neoplasms (Ovarian Cancer) 11/2021
1	Nausea 11/2021
1	Inflammation (Inflammations) 11/2021
1	Hematologic Neoplasms (Hematological Malignancy) 01/2021
1	Melanoma (Melanoma, Malignant) 01/2020
1	Anaphylaxis (Anaphylactic Shock) 01/2020
1	Weight Loss (Weight Reduction) 01/2020
1	Erdheim-Chester Disease 01/2020
1	Hypertension (High Blood Pressure) 01/2020
1	Squamous Cell Carcinoma of Head and Neck 01/2019
1	Septic Shock (Toxic Shock Syndrome) 01/2017
1	Heart Failure 01/2017
1	Thrombocytopenia (Thrombopenia) 01/2017
1	Hypoxia (Hypoxemia) 01/2017
1	Sepsis (Septicemia) 01/2017
1	Lactic Acidosis 01/2017
1	Left Ventricular Dysfunction 10/2016
1	Neoplasm Metastasis (Metastasis) 10/2016
1	Infections 10/2016
1	Infarction (Infarctions) 10/2016
1	Osteosarcoma (Osteogenic Sarcoma) 10/2016
1	Cardiotoxicity 12/2015

3	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2017 - 12/2015
2	cabozantinibIBA 06/2022 - 01/2020
2	PlatinumIBA 11/2021 - 01/2019
2	Cetuximab (Erbitux)FDA Link 03/2020 - 01/2012
2	Imatinib Mesylate (Gleevec)FDA Link 01/2020 - 01/2019
2	ProdrugsIBA 01/2017 - 12/2015
1	liposomal doxorubicin (Doxil)FDA Link 11/2021
1	PM 01183IBA 11/2021
1	Topotecan (Hycamtin)FDA LinkGeneric 11/2021
1	1-dodecylpyridoxal (PLD)IBA 11/2021
1	Enzyme Inhibitors (Inhibitors, Enzyme)IBA 01/2021
1	pevonedistatIBA 01/2021
1	EnzymesIBA 01/2021
1	Proteins (Proteins, Gene)FDA Link 03/2020
1	ErbB Receptors (EGF Receptor)IBA 03/2020
1	Polysorbates (PSML)FDA Link 01/2020
1	Tyrosine Kinase InhibitorsIBA 01/2020
1	VemurafenibIBA 01/2020
1	Sunitinib (Sutent)FDA Link 01/2020
1	Excipients (Suspending Agents)IBA 01/2020
1	Proto-Oncogene Proteins B-rafIBA 01/2020
1	durvalumabIBA 01/2019
1	Monoclonal AntibodiesIBA 01/2019
1	LigandsIBA 01/2019
1	TH 302IBA 01/2017
1	isophosphamide mustard (IPAM)IBA 01/2017
1	Methotrexate (Mexate)FDA LinkGeneric 10/2016
1	Ifosfamide FDA LinkGeneric 10/2016
1	Etoposide (VP 16)FDA LinkGeneric 10/2016
1	Cisplatin (Platino)FDA LinkGeneric 10/2016
1	AlbuminsIBA 12/2015
1	DOXO-EMCHIBA 12/2015
1	Vinorelbine (Navelbine)FDA LinkGeneric 05/2014
1	Everolimus FDA Link 05/2014
1	taxaneIBA 05/2014
1	benthiocarb (Bolero)IBA 05/2014
1	Trastuzumab (Herceptin)FDA Link 05/2014
1	Codon (Codons)IBA 01/2012
1	Estrogen ReceptorsIBA 09/2010
1	Fulvestrant (Faslodex)FDA Link 09/2010